JUN 25, 2019 11:16 AM PDT

Cholesterol Medication May Double Type 2 Diabetes Risk

WRITTEN BY: Nouran Amin

A research study examining thousands of patient’s health records found an association between prescribed cholesterol-lowering statins and the risk of developing type 2 diabetes. "The fact that increased duration of statin use was associated with an increased risk of diabetes -- something we call a dose-dependent relationship -- makes us think that this is likely a causal relationship," said Victoria Zigmont, who led the study as a graduate student in public health at The Ohio State University.

Retrieved from Ohio State University: Ohio State research found a higher risk of diabetes for people prescribed a cholesterol-lowering medication for heart disease prevention

Findings were published in Diabetes Metabolism Research and Reviews, and examined data from 4,683 patients who did not have diabetes and were candidates for statins. Results showed that statin use has in fact doubled the risk of Type 2 diabetes in comparison to those who did not take statin. Risk was even three times higher for those on statin therapy for more than two years.

"In addition, researchers conducting large prospective cohort studies should be considering how statins impact human health overall. They should consider both risks and benefits, not just the disease that is being treated by the specific drug," said co-author Steven Clinton, a professor of medicine and member of Ohio State's Comprehensive Cancer Center.

Statins are a class of drugs that treat patients at risk for a heart attack and stroke by reducing their cholesterol and blood pressure. According to federal estimates, more than 25 percent of middle-aged adults are prescribed cholesterol-lowering drugs.

"That said, statins are very effective in preventing heart attacks and strokes. I would never recommend that people stop taking the statin they've been prescribed based on this study, but it should open up further discussions about diabetes prevention and patient and provider awareness of the issue,” said Zigmont.

Learn more about statin therapy:

Source: Ohio State University

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
NOV 24, 2019
Drug Discovery & Development
NOV 24, 2019
The Fight Against Lethal Childhood Brain Cancers
Scientists used studies on cell and animal models to reveal insights into lethal childhood brain cancers and find promising drug therapeutics. The deadly c...
DEC 04, 2019
Neuroscience
DEC 04, 2019
Single Dose Ketamine Could Rewire Alcohol, Drug Dependance
Presentation by Tobias Stephenson about previous research exploring ketamine as an addiction treatment.    Researchers at University College Lond...
DEC 12, 2019
Drug Discovery & Development
DEC 12, 2019
Probiotics Treat Alcohol-Induced Liver Injury
Alcoholic liver injury is caused by overconsumption of alcohol, something that can lead to serious diseases such as liver steatosis, liver cirrhosis and li...
JAN 02, 2020
Drug Discovery & Development
JAN 02, 2020
FDA Approves Ovarian Cancer Drug to Treat Pancreatic Cancer
In 2019, an estimated 46,000 Americans died from pancreatic cancer. Now, the Food and Drug Administration (FDA) has approved Lynparza, an ovarian cancer dr...
JAN 04, 2020
Cardiology
JAN 04, 2020
New Protein Therapy Improves Heart Attack Survival Rates
Heart disease is the top killer in the Western world. This is partially because, if one manages to survive an initial heart attack, oftentimes the scar tis...
FEB 12, 2020
Drug Discovery & Development
FEB 12, 2020
Does Traditional Chinese Medicine Work Against Coronavirus?
Over 45,000 cases of Wuhan Coronavirus have been reported globally, alongside over 1,100 deaths. Although over 4,700 people are said to have recovered from...
Loading Comments...